Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Other Non-Current Assets: 2019-2024

Historic Other Non-Current Assets for Beam Therapeutics (BEAM) over the last 6 years, with Dec 2024 value amounting to $8.1 million.

  • Beam Therapeutics' Other Non-Current Assets rose 1.63% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 1.63%. This contributed to the annual value of $8.1 million for FY2024, which is 6.59% down from last year.
  • According to the latest figures from FY2024, Beam Therapeutics' Other Non-Current Assets is $8.1 million, which was down 6.59% from $8.7 million recorded in FY2023.
  • In the past 5 years, Beam Therapeutics' Other Non-Current Assets registered a high of $14.8 million during FY2020, and its lowest value of $8.1 million during FY2024.
  • Over the past 3 years, Beam Therapeutics' median Other Non-Current Assets value was $8.7 million (recorded in 2023), while the average stood at $9.9 million.
  • As far as peak fluctuations go, Beam Therapeutics' Other Non-Current Assets climbed by 11.31% in 2020, and later crashed by 31.64% in 2023.
  • Yearly analysis of 5 years shows Beam Therapeutics' Other Non-Current Assets stood at $14.8 million in 2020, then fell by 14.11% to $12.7 million in 2021, then grew by 0.06% to $12.8 million in 2022, then tumbled by 31.64% to $8.7 million in 2023, then fell by 6.59% to $8.1 million in 2024.